Ishares Msci Italy ETF vs Medtronic PLC — how do they compare? Ishares Msci Italy ETF trades at $63.25, while Medtronic PLC trades at $90.48 (market cap $114.45B). The key difference: Medtronic PLC pays a 3.22% dividend while Ishares Msci Italy ETF pays none, and Ishares Msci Italy ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| EWI | MDT | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $63.35 | $105.35 |
52-Week Low | $50.31 | $73.75 |
Market Cap | — | $114.45B |
Enterprise Value | — | $133.19B |
Dividend Yield | — | 3.22% |
Signals from Pluang's Aura AI — not financial advice
EWI, a US-listed stock, trades at $63.35, up 0.3% on the day, with technical indicators showing a bullish moving average trend but overbought oscillators. The stock recently hit a 52-week high, reflecting strong momentum. A dividend of $1.17 is scheduled for payment in June 2026, offering income potential. Recent news highlights European market strength and ECB policy impacts, which may influence EWI's performance given its European exposure.
The outlook for EWI is cautiously optimistic, driven by technical strength and positive European equity trends. Risks include potential ECB rate hikes and geopolitical tensions affecting energy costs. Analyst sentiment is mixed, with the stock near highs suggesting limited upside without new catalysts. Investors should weigh technical overbought signals against fundamental growth prospects.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
EWI is a country-specific ETF that tracks the performance of the Italian equity market. It provides targeted access to large and mid-sized companies in Italy, with a heavy focus on the financial sector and holdings like UniCredit and Intesa Sanpaolo.
Read more on EWI →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →